Scaling/Commercialization

Hot keys for business analysis and commercialization
Scaling/Commercialization
A clear commercialization strategy is imperative for success, says expertA clear commercialization strategy is imperative for success, says expert

There is not one specific path to commercialization said panelists at Biotech Showcase, but the one taken must have a clear strategy from early on.

byLisa Henderson
Jan 27, 2025
|
1 Min Read
Alex Fink, Senior Vice President, and Ed Salzman, Senior Strategic Advisor, both with Lumanity, discuss commercial readiness of biotechs
Sponsored Content
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
byBIO-Europe 2024
Dec 18, 2024
9 Min View
@Informa BIO-Europe 2024, CEO of Cellevate interview
Sponsored Content
Scale Up and Boost Your Viral Vector ProductionScale Up and Boost Your Viral Vector Production
byBIO-Europe 2024
Dec 17, 2024
4 Min View
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 20232023 industry trends that helped evolve biotech innovation
Sep 21, 2024
1 Min Read
CEO of Poseida, Kristin Yarema
Business Strategy
Poseida: New CEO, same passion for allogeneic therapiesPoseida: New CEO, same passion for allogeneic therapies
byMillie Nelson
Feb 26, 2024
1 Min Read
Broken heart
Partnering
It’s not me, it’s you! Experts on when you should dump your CDMOExperts on when you should dump your CDMO
byMillie Nelson
Sep 22, 2023
1 Min Read
Note with politics written on it
Business Strategy
Patient access is political, say CGT experts
Patient access is political, say CGT experts
Jan 9, 2023
|
1 Min Read
byMillie Nelson, Editor

BIO-EUROPE COVERAGE

Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Sponsored Content
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech

Latest

Male being kept up at night and unable to sleep
Investment
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Mar 17 - Mar 19, 2025
Europe's Largest Springtime Biotech Partnering Event
REGISTER
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated